Dan Lü
- Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease 5
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 2
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 3
- Protein Structure and Dynamics 2
- RNA regulation and disease 2
- Cancer Research top 10%
- Oncology top 10%
- Cancer-related Molecular Pathways 3
-
- Synthesis and Characterization of Pyrroles 2
-
- Nanoplatforms for cancer theranostics 2
- Co-authors
- Tsonwin HaiJessie L.‐S. AuM. Guillaume WientjesSeong H. JangDavid RonCurt D. WolfgangJingchun ChenDouglas D. Boyd
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Molecular and Cellular Biology (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Dan Lü
34 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 126
- Cell Biology 473
- Biomaterials 300
- Molecular Biology 1.1k
- Cancer Research 201
- Oncology 277
Countries citing papers authored by Dan Lü
This map shows the geographic impact of Dan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Lü more than expected).
Fields of papers citing papers by Dan Lü
This network shows the impact of papers produced by Dan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Lü. The network helps show where Dan Lü may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dan Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 0 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 19 | |
| 9 | 2021 | 51 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 35 | |
| 12 | 2015 | 11 | |
| 13 | 2009 | 43 | |
| 14 | 2008 | 83 | |
| 15 | 2006 | 172 | |
| 16 | 2005 | 14 | |
| 17 | 2005 | 180 | |
| 18 | 2004 | 409 | |
| 19 | 2003 | 373 | |
| 20 | 2002 | 33 |
About Dan Lü
Dan Lü is a scholar working on Biotechnology, Cell Biology, Molecular Biology, Biomaterials and Oncology, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (5 papers), CRISPR and Genetic Engineering (3 papers), Cancer-related Molecular Pathways (3 papers), Protein Structure and Dynamics (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Synthesis and Characterization of Pyrroles (2 papers), Nanoplatforms for cancer theranostics (2 papers) and RNA regulation and disease (2 papers). The work is most often cited by research in Cell Biology (473 citations), Biomaterials (300 citations), Molecular Biology (1.1k citations), Cancer Research (201 citations) and Oncology (277 citations). Dan Lü has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Tsonwin Hai, Jessie L.‐S. Au, M. Guillaume Wientjes, Seong H. Jang, David Ron, Curt D. Wolfgang, Jingchun Chen, Douglas D. Boyd, Chunhong Yan and Heather P. Harding. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Molecular and Cellular Biology, Journal of Enzyme Inhibition and Medicinal Chemistry, Bioinformatics and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.